These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22220692)
21. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. Picker SM; Steisel A; Gathof BS Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255 [TBL] [Abstract][Full Text] [Related]
22. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169 [TBL] [Abstract][Full Text] [Related]
23. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels. Wagner SJ; Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Moroff G Transfusion; 2010 May; 50(5):1028-35. PubMed ID: 20030790 [TBL] [Abstract][Full Text] [Related]
24. Bioenergetic profiling of platelet mitochondria during storage: 4°C storage extends platelet mitochondrial function and viability. Bynum JA; Meledeo MA; Getz TM; Rodriguez AC; Aden JK; Cap AP; Pidcoke HF Transfusion; 2016 Mar; 56 Suppl 1():S76-84. PubMed ID: 27001365 [TBL] [Abstract][Full Text] [Related]
25. In vitro properties of platelets stored in three different additive solutions. Tynngård N; Trinks M; Berlin G Transfusion; 2012 May; 52(5):1003-9. PubMed ID: 22043825 [TBL] [Abstract][Full Text] [Related]
26. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Sweeney J; Kouttab N; Holme S; Kurtis J; Cheves T; Nelson E Transfusion; 2006 May; 46(5):835-40. PubMed ID: 16686852 [TBL] [Abstract][Full Text] [Related]
27. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage. Li J; Goodrich L; Hansen E; Edrich R; Gampp D; Goodrich RP Transfusion; 2005 Nov; 45(11):1750-8. PubMed ID: 16271100 [TBL] [Abstract][Full Text] [Related]
28. Effects of immediate or delayed addition of platelet additive solution on the in vitro quality of apheresis platelets. Ringwald J; Tully S; Geier C; Hauck B; Weiss D; Callaert M; Eckstein R Transfusion; 2012 Jun; 52(6):1237-44. PubMed ID: 22070790 [TBL] [Abstract][Full Text] [Related]
29. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Skripchenko A; Kurtz J; Moroff G; Wagner SJ Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181 [TBL] [Abstract][Full Text] [Related]
30. Interruption of agitation of platelet concentrates: effects on in vitro parameters. van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J; Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643 [TBL] [Abstract][Full Text] [Related]
31. Platelets stored in a new-generation container differences between plasma and platelet additive solution II. de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410 [TBL] [Abstract][Full Text] [Related]
32. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma versus bicarbonated Ringer's solution with less than 5% plasma. Oikawa S; Sasaki D; Kikuchi M; Sawamura Y; Itoh T Transfusion; 2013 Mar; 53(3):655-60. PubMed ID: 22804481 [TBL] [Abstract][Full Text] [Related]
34. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Cookson P; Thomas S; Marschner S; Goodrich R; Cardigan R Transfusion; 2012 May; 52(5):983-94. PubMed ID: 22014032 [TBL] [Abstract][Full Text] [Related]
35. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets. Dumont LJ; Gulliksson H; van der Meer PF; Murphy S; Nixon JG; de Wildt-Eggen J; Vandenbroeke T; Aubuchon JP Transfusion; 2007 Sep; 47(9):1666-73. PubMed ID: 17725732 [TBL] [Abstract][Full Text] [Related]
36. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days. Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814 [TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788 [TBL] [Abstract][Full Text] [Related]
38. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study. Picker SM; Steisel A; Gathof BS Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725 [TBL] [Abstract][Full Text] [Related]
39. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation. Javela K; Eronen J; Sarna S; Kekomäki R Transfusion; 2005 Sep; 45(9):1504-11. PubMed ID: 16131384 [TBL] [Abstract][Full Text] [Related]
40. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality. Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]